These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12777965)

  • 1. CYP2E1 and NQO1 genotypes, smoking and bladder cancer.
    Choi JY; Lee KM; Cho SH; Kim SW; Choi HY; Lee SY; Im HJ; Yoon KJ; Choi H; Choi I; Hirvonen A; Hayes RB; Kang D
    Pharmacogenetics; 2003 Jun; 13(6):349-55. PubMed ID: 12777965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans.
    Eom SY; Zhang YW; Kim SH; Choe KH; Lee KY; Park JD; Hong YC; Kim YD; Kang JW; Kim H
    Cancer Causes Control; 2009 Mar; 20(2):137-45. PubMed ID: 18798003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms in NQO1 and SOD2: interactions with smoking, schistosoma infection, and bladder cancer risk in Egypt.
    Goerlitz D; Amr S; Dash C; Saleh DA; El Daly M; Abdel-Hamid M; El Kafrawy S; Hifnawy T; Ezzat S; Abdel-Aziz MA; Khaled H; Zheng YL; Mikhail N; Loffredo CA
    Urol Oncol; 2014 Jan; 32(1):47.e15-20. PubMed ID: 24035474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NQO1 609C>T polymorphism interaction with tobacco smoking and alcohol drinking increases colorectal cancer risk in a Chinese population.
    Peng XE; Jiang YY; Shi XS; Hu ZJ
    Gene; 2013 May; 521(1):105-10. PubMed ID: 23458878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning.
    Wan J; Shi J; Hui L; Wu D; Jin X; Zhao N; Huang W; Xia Z; Hu G
    Environ Health Perspect; 2002 Dec; 110(12):1213-8. PubMed ID: 12460800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An association between NQO1 genetic polymorphism and risk of bladder cancer.
    Park SJ; Zhao H; Spitz MR; Grossman HB; Wu X
    Mutat Res; 2003 Apr; 536(1-2):131-7. PubMed ID: 12694753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2E1 and NQO1 genotypes and bladder cancer risk in a Lebanese population.
    Basma HA; Kobeissi LH; Jabbour ME; Moussa MA; Dhaini HR
    Int J Mol Epidemiol Genet; 2013; 4(4):207-17. PubMed ID: 24319536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome p450 2E1 polymorphisms and the risk of gastric cardia cancer.
    Cai L; Zheng ZL; Zhang ZF
    World J Gastroenterol; 2005 Mar; 11(12):1867-71. PubMed ID: 15793883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human NAD(P)H:quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms and urothelial cancer risk in Taiwan.
    Wang YH; Lee YH; Tseng PT; Shen CH; Chiou HY
    J Cancer Res Clin Oncol; 2008 Feb; 134(2):203-9. PubMed ID: 17619904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of NQO1 Pro187Ser or SULT1A1 Arg213His polymorphism and smoking on bladder cancer risk: Two meta-analyses.
    Wang XC; Wang J; Tao HH; Zhang C; Xu LF
    Int J Occup Med Environ Health; 2017 Jul; 30(5):791-802. PubMed ID: 28589969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in the cytochrome P450 1A1 and 2E1 genes, smoking, drinking and prostate cancer susceptibility: a case-control study in a Han nationality population in Southern China.
    Yang J; Qian LX; Wu HF; Xu ZQ; Sui YG; Wang XR; Zhang W
    Int J Urol; 2006 Jun; 13(6):773-80. PubMed ID: 16834659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in NQO1 and MPO genes and risk for bladder cancer in Tunisian population.
    Hemissi I; Ayed H; Naimi Z; Meddeb K; Ayadi M; Zouari S; Zaghbib S; Talbi E; Chebil M; Ouerhani S
    Mol Genet Genomic Med; 2021 Nov; 9(11):e1819. PubMed ID: 34549902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants of NQO1 gene increase bladder cancer risk in Indian population and meta-analysis.
    Mandal RK; Dubey S; Panda AK; Mittal RD
    Tumour Biol; 2014 Jul; 35(7):6415-23. PubMed ID: 24676794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.
    van der Logt EM; Bergevoet SM; Roelofs HM; Te Morsche RH; Dijk Yv; Wobbes T; Nagengast FM; Peters WH
    Mutat Res; 2006 Jan; 593(1-2):39-49. PubMed ID: 16039674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of polymorphisms in iNOS and NQO1 with bladder cancer risk in cigarette smokers.
    Huang ZM; Chen HA; Chiang YT; Shen CH; Tung MC; Juang GD
    J Chin Med Assoc; 2014 Feb; 77(2):83-8. PubMed ID: 24315573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 2E1 genetic polymorphism and gastric cancer in Changle, Fujian Province.
    Cai L; Yu SZ; Zhan ZF
    World J Gastroenterol; 2001 Dec; 7(6):792-5. PubMed ID: 11854903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
    Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
    Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP1A1, GSTM1, GSTT1 and NQO1 polymorphisms and colorectal adenomas in Japanese men.
    Hamachi T; Tajima O; Uezono K; Tabata S; Abe H; Ohnaka K; Kono S
    World J Gastroenterol; 2013 Jul; 19(25):4023-30. PubMed ID: 23840148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
    Gong M; Yi Q; Wang W
    Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
    Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.